ChemoCentryx
CCXI
#3623
Rank
NZ$6.50 B
Marketcap
NZ$90.40
Share price
0.00%
Change (1 day)
30.06%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.50 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.50 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
NZ$47.86 B 636.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$676.35 B 10,302.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$177.08 B 2,623.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
NZ$197.73 B 2,941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$856.27 B 13,069.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.34 B 4,596.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$251.91 B 3,774.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$63.85 B 882.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$480.06 B 7,283.59%๐Ÿ‡บ๐Ÿ‡ธ USA